Drivers of inflammation provide valuable targets for new gum disease therapies
A subset of T cells contributes to the inflammation and bone loss that characterizes periodontitis, a severe form of gum disease. According to new research by George Hajishengallis and scientists at the National Institutes of Health, drugs that specifically inhibit these cells may offer an effective therapy.